Publications
Publications, Books, Book Chapters and Reviews by Prof. Marcus Maurer, MD
Use: Start with an overview of all publications. Use tag links to list selected documents or to list an entire category, e.g. Original Work, Books, Book Chapters, Reviews. If you know what you are looking for, enter this term in the search field.
Treffer: 33
Order by:- [r.186] Expert consensus on prophylactic treatment of hereditary angioedema (0)
- [r.177] The icatibant outcome survey: 10 years of experience with icatibant for patients with hereditary angioedema (0)
- [r.128] Disease severity, activity, impact, and control and how to assess them in patients with hereditary angioedema (2)
- [r.122] Hereditary angioedema with normal C1 inhibitor: Update on evaluation and treatment (0)
- [r.051] Long-term prophylaxis of hereditary angioedema with androgen derivates: a critical appraisal and potential alternatives (2)
- [r.045] Hereditary angioedema: an update on available therapeutic options (0)
- [r.037] Treatment of acute attacks of hereditary angioedema (HAE) with the bradykinin B2 receptor antagonist icatibant (0)
- [o.440] Long-term safety and effectiveness of berotralstat for hereditary angioedema: the open-label APeX-S study (0)
- [o.434] Oral once-daily berotralstat for the prevention of hereditary angioedema attacks: a randomized, double-blind, placebo-controlled phase 3 trial (0)
- [o.426] Impact of lanadelumab on health-related quality of life in patients with hereditary angioedema in the HELP study (1)
- [o.404] Lanadelumab demonstrates rapid and sustained prevention of hereditary angioedema attacks (1)
- [o.390] A novel deep intronic SERPING1 variant as a cause of hereditary angioedema due to C1-inhibitor deficiency (1)
- [o.359] Elderly versus younger patients with hereditary angioedema type I/II: patient characteristics and safety analysis from the Icatibant Outcome Survey (0)
- [o.340] Management of patients with hereditary angioedema in Germany: comparison with other countries in the Icatibant Outcome Survey (1)
- [o.337] Guideline: Hereditary angioedema due to C1 inhibitor deficiency. S1-Guideline of the German Society for Angioedema (DGA), German Society for Internal Medicine (DGIM), German Society for Otorhinolaryngology (DGHNO), German Society for Allergology and Clinical Immunology (DGAKI), German Society for Child and Adolescent Medicine (DGKJ), German Dermatological Society (DDG), German Society for Pediatric Allergology and Environmental Medicine (GPA), German Association of ENT Surgeons (BVHNO) and the German HAE Patient Association (HAE-SHG) (0)
- [o.328] Improvement in diagnostic delays over time in patients with hereditary angioedema: findings from the icatibant outcome survey (2)
- [o.326] Evaluation of avoralstat, an oral kallikrein inhibitor, in a phase 3 hereditary angioedema prophylaxis trial: the OPuS-2 study (0)
- [o.309] The international WAO/EAACI guideline for the management of hereditary angioedema – the 2017 revision and update (2)
- [o.308] The international WAO/EAACI guideline for the management of hereditary angioedema – the 2017 revision and update (0)
- [o.302] Effectiveness of icatibant for treatment of hereditary angioedema attacks is not affected by body weight: findings from the icatibant outcome survey, a cohort observational study (2)
(Last update: 08.2023)
| Number of original publications in peer-reviewed journals: | 569 |
| Number of reviews in peer-reviewed journals: | 205 |
| Number of publications (original work and reviews) in peer-reviewed journals: | 774 |
| Cumulative IF for original publications in peer-reviewed journals: | 4106.58 |
| Cumulative IF for reviews in peer-reviewed journals: | 1382.52 |
| Cumulative IF of publications (original work & reviews) in peer-reviewed journals: | 5489.10 |
| Total number of citations: 35,311 h-index: 95 (Web of Science August 2023) | 35311 |